Statins nephrotoxicity

Daptomycin neither inhibits nor induces CYPs, and there are no important drug-drug interactions. However, caution is recommended when administering daptomycin in conjunction with aminoglycosides or statins because of potential risks of nephrotoxicity and myopathy, respectively. 

Drug interactions mediated by CYP3A inhibition can be severe e.g., nephrotoxicity induced by cyclosporine and tacrolimus and rhabdomyolysis resulting from increased levels of statins). Whenever an inhibitor of the CYP3A isoforms is administered, the clinician must be cognizant of the potential for serious interactions with drugs metabolized by CYP3A. 

Statins, see HMG Co-A reductase inhibitors Steroids, see Glucocorticoids Stimulants, in ADHD, 31.4 Sugammadex, 32.275 Sulfonamide derivatives, hypersensitivity reactions, 30.252 Sumatriptan, 17.171 Suprofen, nephrotoxicity, 12.88 Suramin, patients with prostate cancer, 20.283 Surgam, gastric reactions, 12.89 Suxamethonium, postoperative myalgia,... 

---